S
Silo Pharma Inc
NASDAQ:SILO
Silo Pharma Inc
NASDAQ:SILO
Price:
0.3798
USD
2.93%
Market Closed
Market Cap:
$5.1m
Balance Sheet
Balance Sheet Decomposition
Silo Pharma Inc
Silo Pharma Inc
Balance Sheet Decomposition is not available for
Silo Pharma Inc
Silo Pharma Inc
Balance Sheet
Silo Pharma Inc
Silo Pharma Inc
Currency: USD
| Dec-2010 | Dec-2011 | Dec-2012 | Dec-2013 | Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||
| Cash & Cash Equivalents |
0
|
0
|
0
|
2
|
2
|
1
|
1
|
0
|
0
|
0
|
1
|
10
|
11
|
4
|
4
|
|
| Cash Equivalents |
0
|
0
|
0
|
2
|
2
|
1
|
1
|
0
|
0
|
0
|
1
|
10
|
11
|
4
|
4
|
|
| Short-Term Investments |
0
|
0
|
0
|
0
|
1
|
2
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
4
|
3
|
|
| Total Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Inventory |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Assets |
0
|
0
|
0
|
2
|
3
|
2
|
1
|
2
|
1
|
0
|
1
|
10
|
12
|
8
|
7
|
|
| Intangible Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Note Receivable |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
0
N/A
|
0
N/A
|
0
N/A
|
2
N/A
|
3
+25%
|
2
-12%
|
1
-47%
|
2
+26%
|
1
-48%
|
0
-43%
|
1
+192%
|
10
+634%
|
12
+11%
|
8
-33%
|
7
-4%
|
|
| Liabilities | ||||||||||||||||
| Accounts Payable |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
2
|
|
| Accrued Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
2
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
|
| Total Liabilities |
0
N/A
|
0
N/A
|
0
N/A
|
0
-50%
|
0
N/A
|
0
N/A
|
0
-44%
|
0
-20%
|
0
+25%
|
0
+140%
|
0
+25%
|
1
+853%
|
1
-9%
|
2
+21%
|
2
+52%
|
|
| Equity | ||||||||||||||||
| Common Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
1
|
1
|
1
|
1
|
1
|
0
|
0
|
0
|
2
|
3
|
6
|
3
|
7
|
11
|
15
|
|
| Additional Paid In Capital |
1
|
1
|
1
|
3
|
4
|
2
|
2
|
2
|
2
|
3
|
7
|
12
|
18
|
18
|
20
|
|
| Unrealized Security Profit/Loss |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Treasury Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
0
N/A
|
0
N/A
|
0
N/A
|
2
N/A
|
3
+26%
|
2
-15%
|
1
-47%
|
2
+28%
|
1
-49%
|
0
-53%
|
1
+237%
|
9
+608%
|
10
+14%
|
6
-40%
|
5
-18%
|
|
| Total Liabilities & Equity |
0
N/A
|
0
N/A
|
0
N/A
|
2
N/A
|
3
+25%
|
2
-12%
|
1
-47%
|
2
+26%
|
1
-48%
|
0
-43%
|
1
+192%
|
10
+634%
|
12
+11%
|
8
-33%
|
7
-4%
|
|
| Shares Outstanding | ||||||||||||||||
| Common Shares Outstanding |
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
0
|
0
|
2
|
2
|
3
|
3
|
4
|
|
| Preferred Shares Outstanding |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Switch to:
Switch to:
See Also
Discover More
